Copyright Reports & Markets. All rights reserved.

Global DNA Cloning Service Market Research Report 2022

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
  • 1.2.1 Global DNA Cloning Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 Cloning Service
  • 1.2.3 Subcloning Service
  • 1.2.4 Mutagenesis Service
  • 1.2.5 Others
  • 1.3 Market by Application
  • 1.3.1 Global DNA Cloning Service Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Laboratory
  • 1.3.3 Research Institute
  • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global DNA Cloning Service Market Perspective (2017-2028)
    • 2.2 DNA Cloning Service Growth Trends by Region
    • 2.2.1 DNA Cloning Service Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 DNA Cloning Service Historic Market Size by Region (2017-2022)
  • 2.2.3 DNA Cloning Service Forecasted Market Size by Region (2023-2028)
  • 2.3 DNA Cloning Service Market Dynamics
  • 2.3.1 DNA Cloning Service Industry Trends
  • 2.3.2 DNA Cloning Service Market Drivers
  • 2.3.3 DNA Cloning Service Market Challenges
  • 2.3.4 DNA Cloning Service Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top DNA Cloning Service Players by Revenue
    • 3.1.1 Global Top DNA Cloning Service Players by Revenue (2017-2022)
  • 3.1.2 Global DNA Cloning Service Revenue Market Share by Players (2017-2022)
  • 3.2 Global DNA Cloning Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by DNA Cloning Service Revenue
  • 3.4 Global DNA Cloning Service Market Concentration Ratio
  • 3.4.1 Global DNA Cloning Service Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by DNA Cloning Service Revenue in 2021
  • 3.5 DNA Cloning Service Key Players Head office and Area Served
  • 3.6 Key Players DNA Cloning Service Product Solution and Service
  • 3.7 Date of Enter into DNA Cloning Service Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 DNA Cloning Service Breakdown Data by Type

    • 4.1 Global DNA Cloning Service Historic Market Size by Type (2017-2022)
    • 4.2 Global DNA Cloning Service Forecasted Market Size by Type (2023-2028)

    5 DNA Cloning Service Breakdown Data by Application

    • 5.1 Global DNA Cloning Service Historic Market Size by Application (2017-2022)
    • 5.2 Global DNA Cloning Service Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America DNA Cloning Service Market Size (2017-2028)
    • 6.2 North America DNA Cloning Service Market Size by Country (2017-2022)
    • 6.3 North America DNA Cloning Service Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe DNA Cloning Service Market Size (2017-2028)
    • 7.2 Europe DNA Cloning Service Market Size by Country (2017-2022)
    • 7.3 Europe DNA Cloning Service Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific DNA Cloning Service Market Size (2017-2028)
    • 8.2 Asia-Pacific DNA Cloning Service Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific DNA Cloning Service Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America DNA Cloning Service Market Size (2017-2028)
    • 9.2 Latin America DNA Cloning Service Market Size by Country (2017-2022)
    • 9.3 Latin America DNA Cloning Service Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa DNA Cloning Service Market Size (2017-2028)
    • 10.2 Middle East & Africa DNA Cloning Service Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa DNA Cloning Service Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Eurofins Genomics
    • 11.1.1 Eurofins Genomics Company Detail
  • 11.1.2 Eurofins Genomics Business Overview
  • 11.1.3 Eurofins Genomics DNA Cloning Service Introduction
  • 11.1.4 Eurofins Genomics Revenue in DNA Cloning Service Business (2017-2022)
  • 11.1.5 Eurofins Genomics Recent Development
  • 11.2 Innoprot
  • 11.2.1 Innoprot Company Detail
  • 11.2.2 Innoprot Business Overview
  • 11.2.3 Innoprot DNA Cloning Service Introduction
  • 11.2.4 Innoprot Revenue in DNA Cloning Service Business (2017-2022)
  • 11.2.5 Innoprot Recent Development
  • 11.3 Genewiz
  • 11.3.1 Genewiz Company Detail
  • 11.3.2 Genewiz Business Overview
  • 11.3.3 Genewiz DNA Cloning Service Introduction
  • 11.3.4 Genewiz Revenue in DNA Cloning Service Business (2017-2022)
  • 11.3.5 Genewiz Recent Development
  • 11.4 Bio-Fab Research
  • 11.4.1 Bio-Fab Research Company Detail
  • 11.4.2 Bio-Fab Research Business Overview
  • 11.4.3 Bio-Fab Research DNA Cloning Service Introduction
  • 11.4.4 Bio-Fab Research Revenue in DNA Cloning Service Business (2017-2022)
  • 11.4.5 Bio-Fab Research Recent Development
  • 11.5 VectorBuilder
  • 11.5.1 VectorBuilder Company Detail
  • 11.5.2 VectorBuilder Business Overview
  • 11.5.3 VectorBuilder DNA Cloning Service Introduction
  • 11.5.4 VectorBuilder Revenue in DNA Cloning Service Business (2017-2022)
  • 11.5.5 VectorBuilder Recent Development
  • 11.6 Prospec-Tany Technogene
  • 11.6.1 Prospec-Tany Technogene Company Detail
  • 11.6.2 Prospec-Tany Technogene Business Overview
  • 11.6.3 Prospec-Tany Technogene DNA Cloning Service Introduction
  • 11.6.4 Prospec-Tany Technogene Revenue in DNA Cloning Service Business (2017-2022)
  • 11.6.5 Prospec-Tany Technogene Recent Development
  • 11.7 Addgene
  • 11.7.1 Addgene Company Detail
  • 11.7.2 Addgene Business Overview
  • 11.7.3 Addgene DNA Cloning Service Introduction
  • 11.7.4 Addgene Revenue in DNA Cloning Service Business (2017-2022)
  • 11.7.5 Addgene Recent Development
  • 11.8 Amid Biosciences
  • 11.8.1 Amid Biosciences Company Detail
  • 11.8.2 Amid Biosciences Business Overview
  • 11.8.3 Amid Biosciences DNA Cloning Service Introduction
  • 11.8.4 Amid Biosciences Revenue in DNA Cloning Service Business (2017-2022)
  • 11.8.5 Amid Biosciences Recent Development
  • 11.9 OriGene
  • 11.9.1 OriGene Company Detail
  • 11.9.2 OriGene Business Overview
  • 11.9.3 OriGene DNA Cloning Service Introduction
  • 11.9.4 OriGene Revenue in DNA Cloning Service Business (2017-2022)
  • 11.9.5 OriGene Recent Development
  • 11.10 Applied Biological Materials
  • 11.10.1 Applied Biological Materials Company Detail
  • 11.10.2 Applied Biological Materials Business Overview
  • 11.10.3 Applied Biological Materials DNA Cloning Service Introduction
  • 11.10.4 Applied Biological Materials Revenue in DNA Cloning Service Business (2017-2022)
  • 11.10.5 Applied Biological Materials Recent Development
  • 11.11 Gemini Biosciences
  • 11.11.1 Gemini Biosciences Company Detail
  • 11.11.2 Gemini Biosciences Business Overview
  • 11.11.3 Gemini Biosciences DNA Cloning Service Introduction
  • 11.11.4 Gemini Biosciences Revenue in DNA Cloning Service Business (2017-2022)
  • 11.11.5 Gemini Biosciences Recent Development
  • 11.12 Creative Biogene
  • 11.12.1 Creative Biogene Company Detail
  • 11.12.2 Creative Biogene Business Overview
  • 11.12.3 Creative Biogene DNA Cloning Service Introduction
  • 11.12.4 Creative Biogene Revenue in DNA Cloning Service Business (2017-2022)
  • 11.12.5 Creative Biogene Recent Development
  • 11.13 Canvax
  • 11.13.1 Canvax Company Detail
  • 11.13.2 Canvax Business Overview
  • 11.13.3 Canvax DNA Cloning Service Introduction
  • 11.13.4 Canvax Revenue in DNA Cloning Service Business (2017-2022)
  • 11.13.5 Canvax Recent Development
  • 11.14 Varigen Biosciences
  • 11.14.1 Varigen Biosciences Company Detail
  • 11.14.2 Varigen Biosciences Business Overview
  • 11.14.3 Varigen Biosciences DNA Cloning Service Introduction
  • 11.14.4 Varigen Biosciences Revenue in DNA Cloning Service Business (2017-2022)
  • 11.14.5 Varigen Biosciences Recent Development
  • 11.15 BioServUK
  • 11.15.1 BioServUK Company Detail
  • 11.15.2 BioServUK Business Overview
  • 11.15.3 BioServUK DNA Cloning Service Introduction
  • 11.15.4 BioServUK Revenue in DNA Cloning Service Business (2017-2022)
  • 11.15.5 BioServUK Recent Development
  • 11.16 Cellomics Technology
  • 11.16.1 Cellomics Technology Company Detail
  • 11.16.2 Cellomics Technology Business Overview
  • 11.16.3 Cellomics Technology DNA Cloning Service Introduction
  • 11.16.4 Cellomics Technology Revenue in DNA Cloning Service Business (2017-2022)
  • 11.16.5 Cellomics Technology Recent Development
  • 11.17 Charles River Laboratories
  • 11.17.1 Charles River Laboratories Company Detail
  • 11.17.2 Charles River Laboratories Business Overview
  • 11.17.3 Charles River Laboratories DNA Cloning Service Introduction
  • 11.17.4 Charles River Laboratories Revenue in DNA Cloning Service Business (2017-2022)
  • 11.17.5 Charles River Laboratories Recent Development
  • 11.18 Chromous Biotech
  • 11.18.1 Chromous Biotech Company Detail
  • 11.18.2 Chromous Biotech Business Overview
  • 11.18.3 Chromous Biotech DNA Cloning Service Introduction
  • 11.18.4 Chromous Biotech Revenue in DNA Cloning Service Business (2017-2022)
  • 11.18.5 Chromous Biotech Recent Development
  • 11.19 Epoch Life Science
  • 11.19.1 Epoch Life Science Company Detail
  • 11.19.2 Epoch Life Science Business Overview
  • 11.19.3 Epoch Life Science DNA Cloning Service Introduction
  • 11.19.4 Epoch Life Science Revenue in DNA Cloning Service Business (2017-2022)
  • 11.19.5 Epoch Life Science Recent Development
  • 11.20 GW Vitek
  • 11.20.1 GW Vitek Company Detail
  • 11.20.2 GW Vitek Business Overview
  • 11.20.3 GW Vitek DNA Cloning Service Introduction
  • 11.20.4 GW Vitek Revenue in DNA Cloning Service Business (2017-2022)
  • 11.20.5 GW Vitek Recent Development
  • 11.21 Immune Technology
  • 11.21.1 Immune Technology Company Detail
  • 11.21.2 Immune Technology Business Overview
  • 11.21.3 Immune Technology DNA Cloning Service Introduction
  • 11.21.4 Immune Technology Revenue in DNA Cloning Service Business (2017-2022)
  • 11.21.5 Immune Technology Recent Development
  • 11.22 Protein Ark
  • 11.22.1 Protein Ark Company Detail
  • 11.22.2 Protein Ark Business Overview
  • 11.22.3 Protein Ark DNA Cloning Service Introduction
  • 11.22.4 Protein Ark Revenue in DNA Cloning Service Business (2017-2022)
  • 11.22.5 Protein Ark Recent Development
  • 11.23 Protomnis
  • 11.23.1 Protomnis Company Detail
  • 11.23.2 Protomnis Business Overview
  • 11.23.3 Protomnis DNA Cloning Service Introduction
  • 11.23.4 Protomnis Revenue in DNA Cloning Service Business (2017-2022)
  • 11.23.5 Protomnis Recent Development
  • 11.24 RD-Biotech
  • 11.24.1 RD-Biotech Company Detail
  • 11.24.2 RD-Biotech Business Overview
  • 11.24.3 RD-Biotech DNA Cloning Service Introduction
  • 11.24.4 RD-Biotech Revenue in DNA Cloning Service Business (2017-2022)
  • 11.24.5 RD-Biotech Recent Development
  • 11.25 Synbio Technologies
  • 11.25.1 Synbio Technologies Company Detail
  • 11.25.2 Synbio Technologies Business Overview
  • 11.25.3 Synbio Technologies DNA Cloning Service Introduction
  • 11.25.4 Synbio Technologies Revenue in DNA Cloning Service Business (2017-2022)
  • 11.25.5 Synbio Technologies Recent Development
  • 11.26 Twist Bioscience
  • 11.26.1 Twist Bioscience Company Detail
  • 11.26.2 Twist Bioscience Business Overview
  • 11.26.3 Twist Bioscience DNA Cloning Service Introduction
  • 11.26.4 Twist Bioscience Revenue in DNA Cloning Service Business (2017-2022)
  • 11.26.5 Twist Bioscience Recent Development
  • 11.27 GenScript
  • 11.27.1 GenScript Company Detail
  • 11.27.2 GenScript Business Overview
  • 11.27.3 GenScript DNA Cloning Service Introduction
  • 11.27.4 GenScript Revenue in DNA Cloning Service Business (2017-2022)
  • 11.27.5 GenScript Recent Development
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Disclaimer
    • Industry Insights
      The global DNA Cloning Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

      Fully considering the economic change by this health crisis, Cloning Service accounting for % of the DNA Cloning Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Laboratory segment is altered to an % CAGR throughout this forecast period.

      China DNA Cloning Service market size is valued at US$ million in 2021, while the North America and Europe DNA Cloning Service are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe DNA Cloning Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

      With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global DNA Cloning Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global DNA Cloning Service market in terms of revenue.

      Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global DNA Cloning Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global DNA Cloning Service market.

      Impact of Covid-19 Outbreak

      This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

      Segmental Analysis

      The report has been segmented into product and application segments. The researchers have documented all the products present today in the DNA Cloning Service market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

      DNA Cloning Service Breakdown Data by Type

      Cloning Service

      Subcloning Service

      Mutagenesis Service

      Others

      DNA Cloning Service Breakdown Data by Application

      Laboratory

      Research Institute

      Others

      Regional Analysis

      North America

      United States

      Canada

      Europe

      Germany

      France

      UK

      Italy

      Russia

      Nordic Countries

      Rest of Europe

      Asia-Pacific

      China

      Japan

      South Korea

      Southeast Asia

      India

      Australia

      Rest of Asia

      Latin America

      Mexico

      Brazil

      Rest of Latin America

      Middle East & Africa

      Turkey

      Saudi Arabia

      UAE

      Rest of MEA

      Competitive Landscape

      This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

      Eurofins Genomics

      Innoprot

      Genewiz

      Bio-Fab Research

      VectorBuilder

      Prospec-Tany Technogene

      Addgene

      Amid Biosciences

      OriGene

      Applied Biological Materials

      Gemini Biosciences

      Creative Biogene

      Canvax

      Varigen Biosciences

      BioServUK

      Cellomics Technology

      Charles River Laboratories

      Chromous Biotech

      Epoch Life Science

      GW Vitek

      Immune Technology

      Protein Ark

      Protomnis

      RD-Biotech

      Synbio Technologies

      Twist Bioscience

      GenScript

      Frequently Asked Questions

      What factors will challenge the DNA Cloning Service market growth?

      Which end-use segment will expand at the fastest CAGR in the DNA Cloning Service market?

      Which are the emerging players in the DNA Cloning Service market?

      How concentrated is the DNA Cloning Service market?

      Which factors are positively contributing to the DNA Cloning Service market growth?

      Which are the novel product innovations in the DNA Cloning Service market?

      Which product segment will emerge as the most lucrative in the DNA Cloning Service market?

      Which factors are increasing the competition in the DNA Cloning Service market?

      Which are the strategic measures taken by the DNA Cloning Service industry players?

      Which region will witness inactive growth during the forecast period?

      What key trends are likely to emerge in the DNA Cloning Service market in the coming years?

      Buy now